Contributes reviews on supplier material. Based in Nairobi.
member · joined 14 May 2025
Overview — page 5 of 5
comment on [Meta] the 503B rule is doing its job and people should stop complaining in c/compounding · 1 points · 1 year ago
the shortage list is temporary, it ends and compounding becomes illegal again
comment on genuine question about external review that I am slightly embarrassed to ask in c/insurancefights · 97 points · 2 years ago
Sceptical.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on genuine question about external review that I am slightly embarrassed to ask in c/insurancefights · 103 points · 2 years ago
Denied for prior auth, resubmitted with step therapy documentation, approved on appeal. The criteria exist, you just have to meet them.
comment on genuine question about external review that I am slightly embarrassed to ask in c/insurancefights · 200 points · 2 years ago
Sweden plan: step therapy required 3 medications first. Did them all, got approval. The order matters.
Right, the formulary question again, but with numbers this time. I have 24 data points over 12 weeks. The pattern is consistent enough that I do not think it is chance,…
comment on [Vendor] WXT order #17 — the Netherlands, 9 days, no drama, receipts inside in c/glp1uk · 56 points · 2 years ago
Titration speed is a side-effect dial far more than an efficacy dial.
comment on Denmark: Wegovy, and what it actually costs here in c/semaglutide · 103 points · 2 years ago
I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.
comment on is it normal to get muscle cramps at week 84 in c/maintenancephase · 31 points · 2 years ago
Tried the lowest-effective approach. 15mg worked for 7 weeks, then cravings returned. 10mg was the actual floor.
comment on what would you tell week-1 you about private prescription in c/glp1uk · 316 points · 2 years ago
MHRA supply notices change monthly, follow the actual list
comment on switched from 10mg to 0.25mg and the constipation got better, not worse in c/insurancefights · 10 points · 2 years ago
the carve-out clause varies by employer
comment on help me understand 503A, I have read the wiki twice in c/compounding · 10 points · 2 years ago
This is correct. The shortage list does expire and the rules change.
comment on regain — my 8-week log, condensed into one table in c/maintenancephase · 29 points · 2 years ago
the long term question changes at maintenance
comment on stalled for 6 weeks at 2.4mg and I refuse to panic this time in c/insurancefights · 132 points · 2 years ago
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.
comment on [Lab] SGN survo — VendorInvestigate came back 93.7% against a claimed 98.6% in c/compounding · 450 points · 2 years ago
Asked 18 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.
comment on [Lab] SSA sema — Medutest came back 97.4% against a claimed 96.2% in c/semaglutide · 14 points · 2 years ago
okay but what dose of sema are you on
comment on stalled for 16 weeks at 12.5mg and I refuse to panic this time in c/semaglutide · 2 points · 2 years ago
my eGFR moved before the scale did and i nearly missed it
comment on small win: Ozempic stopped being a problem at week 20 in c/semaglutide · 535 points · 2 years ago
week 83 on the pen, 46kg down, this is the answer
No trophies yet. Most accounts here never get one.
Independent testing plus vendor-level trend data. Community-funded, unaffiliated.
peptidemeter.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference